Dopamine D2 receptor dimers in human and rat brain (Q42059351)

15 October 2017

Dopamine D2 receptor dimers in human and rat brain (English)

1 reference

15 October 2017

0 references

Zawarynski P

1

1 reference

15 October 2017

Tallerico T

2

1 reference

15 October 2017

Seeman P

3

1 reference

15 October 2017

Lee SP

4

1 reference

15 October 2017

O'Dowd BF

5

1 reference

15 October 2017

George SR

6

1 reference

15 October 2017

language of work or name

English

0 references

publication date

1 December 1998

1 reference

15 October 2017

1 reference

15 October 2017

441

1 reference

15 October 2017

3

1 reference

15 October 2017

383-386

1 reference

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride

15 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901588-9

Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901588-9

The cloned dopamine D2 receptor reveals different densities for dopamine receptor antagonist ligands. Implications for human brain positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901588-9

Critical reevaluation of spiperone and benzamide binding to dopamine D2 receptors: evidence for identical binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901588-9

Dopamine D2 receptor dimers and receptor-blocking peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901588-9

Synthesis and neuroleptic activity of benzamides. Cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide and related compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901588-9

Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901588-9

A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901588-9

Cardiac muscarinic receptors. Cooperativity as the basis for multiple states of affinity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901588-9

Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901588-9

Dopamine D2 receptor density estimates in schizophrenia: a positron emission tomography study with 11C-N-methylspiperone

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901588-9

In Vivo D2 Dopamine Receptor Density in Psychotic and Nonpsychotic Patients With Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901588-9

Variability in D2-dopamine receptor density and affinity: a PET study with [11C]raclopride in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901588-9

No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901588-9

[3H]nemonapride and [3H]spiperone label equivalent numbers of D2 and D3 dopamine receptors in a range of tissues and under different conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901588-9

Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901588-9

Cooperativity manifest in the binding properties of purified cardiac muscarinic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901588-9

Thr353, located within the COOH-terminal tail of the delta opiate receptor, is involved in receptor down-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901588-9

10.1016/S0014-5793(98)01588-9

21 January 2018

Identifiers

DOI

1 reference

15 October 2017

1 reference